Day: October 22, 2024

La plateforme Quantexa reconnue leader de sa catégorie dans le RiskTech Quadrant® pour ses solutions de connaissance du client

October 22, 2024

La plateforme Quantexa a obtenu une place de choix dans le rapport RiskTech100® 2025, soulignant ainsi sa force et son innovation sur le marché en

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

October 22, 2024

REC-3964 is Recursion’s first new chemical entity developed using the RecursionOS. REC-3964 represents a novel, non-antibiotic approach with a unique mechanism of action that binds

Day: October 22, 2024

La plateforme Quantexa reconnue leader de sa catégorie dans le RiskTech Quadrant® pour ses solutions de connaissance du client

Recursion announces first patient dosed in Phase 2 clinical study of REC-3964, a potential first-in-class, oral, non-antibiotic small molecule for recurrent Clostridioides difficile infection

Press Releases

EMGA obtient 90 millions de dollars américains de la EIB pour BTG Pactual (Brésil)

Syrah’s Balama is the first graphite operation to complete independent audit against the IRMA Standard, achieves IRMA 50

Recent Posts

Financial Injustice and Debt Remain Obstacles to Africa’s Development

G20 Africa Expert Panel Set to Enhance Finance Strategies Under South Africa’s Leadership

Pages

Pages

Recent Posts

Financial Injustice and Debt Remain Obstacles to Africa’s Development

G20 Africa Expert Panel Set to Enhance Finance Strategies Under South Africa’s Leadership

Captain Chetty’s Commitment to Combating Gender-Based Violence in South Africa

Department of Transport Director-General Resigns to Pursue Other Interests

Government Launches Initiative to Attract Investment in Transmission Infrastructure